ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350,000 | -41.0% | 2,958 | -10.9% | 0.00% | – |
| Q2 2023 | $593,000 | +173.3% | 3,320 | +154.2% | 0.00% | – |
| Q1 2023 | $217,000 | -24.1% | 1,306 | -28.0% | 0.00% | – |
| Q4 2022 | $286,000 | -17.3% | 1,815 | -21.1% | 0.00% | – |
| Q3 2022 | $346,000 | -18.6% | 2,299 | -11.0% | 0.00% | – |
| Q2 2022 | $425,000 | -51.9% | 2,584 | -34.8% | 0.00% | – |
| Q1 2022 | $883,000 | +13.8% | 3,965 | +21.3% | 0.00% | – |
| Q4 2021 | $776,000 | +127.6% | 3,268 | +123.5% | 0.00% | – |
| Q3 2021 | $341,000 | -54.4% | 1,462 | -59.8% | 0.00% | – |
| Q2 2021 | $748,000 | +27.4% | 3,639 | +27.5% | 0.00% | – |
| Q1 2021 | $587,000 | -27.2% | 2,855 | -24.0% | 0.00% | – |
| Q4 2020 | $806,000 | +89.6% | 3,759 | +61.9% | 0.00% | – |
| Q3 2020 | $425,000 | -62.0% | 2,322 | -61.7% | 0.00% | – |
| Q2 2020 | $1,117,000 | -36.8% | 6,064 | -30.8% | 0.00% | -100.0% |
| Q1 2020 | $1,768,000 | +11.1% | 8,765 | +3.1% | 0.00% | 0.0% |
| Q4 2019 | $1,591,000 | -10.5% | 8,502 | -23.6% | 0.00% | 0.0% |
| Q3 2019 | $1,777,000 | -43.3% | 11,132 | -10.6% | 0.00% | 0.0% |
| Q2 2019 | $3,135,000 | +27.4% | 12,446 | +21.1% | 0.00% | 0.0% |
| Q1 2019 | $2,461,000 | -4.6% | 10,280 | -8.5% | 0.00% | 0.0% |
| Q4 2018 | $2,581,000 | -59.2% | 11,241 | -49.8% | 0.00% | -66.7% |
| Q3 2018 | $6,332,000 | -83.3% | 22,402 | -82.7% | 0.00% | -82.4% |
| Q2 2018 | $37,922,000 | +1.3% | 129,142 | -13.0% | 0.02% | 0.0% |
| Q1 2018 | $37,451,000 | +13.8% | 148,384 | -2.6% | 0.02% | +21.4% |
| Q4 2017 | $32,917,000 | +15.1% | 152,395 | -1.0% | 0.01% | 0.0% |
| Q3 2017 | $28,605,000 | -4.6% | 153,913 | -11.4% | 0.01% | -6.7% |
| Q2 2017 | $29,975,000 | +14.2% | 173,768 | +1.1% | 0.02% | +7.1% |
| Q1 2017 | $26,252,000 | -9.6% | 171,921 | -12.8% | 0.01% | -12.5% |
| Q4 2016 | $29,051,000 | +12.2% | 197,152 | -3.8% | 0.02% | +6.7% |
| Q3 2016 | $25,903,000 | +10.9% | 204,971 | -1.1% | 0.02% | +7.1% |
| Q2 2016 | $23,365,000 | +70.2% | 207,226 | +57.2% | 0.01% | +55.6% |
| Q1 2016 | $13,725,000 | +1316.4% | 131,830 | +1433.4% | 0.01% | +800.0% |
| Q4 2015 | $969,000 | +61.0% | 8,597 | +56.4% | 0.00% | – |
| Q3 2015 | $602,000 | -17.8% | 5,498 | -28.2% | 0.00% | -100.0% |
| Q2 2015 | $732,000 | -5.3% | 7,660 | -7.8% | 0.00% | 0.0% |
| Q1 2015 | $773,000 | +11.5% | 8,304 | -1.9% | 0.00% | – |
| Q4 2014 | $693,000 | +143.2% | 8,466 | +90.7% | 0.00% | – |
| Q3 2014 | $285,000 | -14.9% | 4,440 | -19.3% | 0.00% | – |
| Q2 2014 | $335,000 | +73.6% | 5,499 | +71.0% | 0.00% | – |
| Q1 2014 | $193,000 | +45.1% | 3,215 | +53.6% | 0.00% | – |
| Q4 2013 | $133,000 | +72.7% | 2,093 | +84.6% | 0.00% | – |
| Q3 2013 | $77,000 | +32.8% | 1,134 | +39.5% | 0.00% | – |
| Q2 2013 | $58,000 | – | 813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |